WPRIM Management System> DCMS> Drug Evaluation Research> 2017> 40> 9

Volume: 40 Issue: 9

1. Effects of atorvastatin on serum levels of inflammatory factors, pulmonary function and right ventricular remodeling in patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension Page:1323—1326
2. Effect of dexmedetomidine on stress response during tracheal intubation in patients with ICU Page:1319—1322
3. Effect and safety of Reteplase for Injection combined with reduced glutathione in treatment of acute ST segment elevation myocardial infarction Page:1315—1318
4. Experimental study of Aripiprazole Injection on muscular irritation, hemolysis and sensitization Page:1270—1273
5. Comparison on clinical effect and safety of minocycline hydrochloride combined with metronidazole or tinidazole in treatment of chronic periodontitis Page:1294—1296
6. Changes of key enzymes involved in testosterone synthesis in testes of early diabetic mice Page:1285—1289
7. Study on bioequivalence of Meloxicam Chewable Tablets Page:1254—1258
8. Discussion on main points of quality control of PEGlated interferons Page:1361—1364
9. Impact of new registration reform on chemical drugs R&D Page:1355—1360
10. Major factors influencing quality of neuropathology evaluation of drug toxicology Page:1348—1354
11. Clinical efficacy and safety of liposomal doxorubicin in treatment of cancer: A systematic review Page:1338—1347
12. Clinical observation on Danshen Chuangxiongqin Injection in treatment of posterior circulation ischemia vertigo Page:1334—1337
13. Therapeutic efficacy of small dosage of methylprednisolone in treatment of sepsis and effect on immune cells Page:1331—1333
14. Effect of Compound Danshen Dripping Pill combined with polyene phosphatidyl choline in treatment of nonalcoholic fatty liver disease Page:1327—1330
15. Effect of clopidogrel on YKL-40 and NF-κB levels in patients undergoing percutaneous coronary intervention with coronary heart disease with diabetes mellitus Page:1310—1314
16. Efficacy and safety of paroxetine in treatment of post-stroke depression and anxiety Page:1306—1309
17. Clinical effect of sevelamer in hyperphosphatemia of chronic renal failure patients with maintenance hemodialysis Page:1302—1305
18. Effect of dexmedetomidine combined with sevoflurane on postoperative sedation for children undergoing ophthalmic operation Page:1297—1301
19. Pharmacokinetic-pharmacodynamic study of apixaban in rats Page:1290—1293
20. Research on prescription screening of Acteoside solid lipid nanoparticles Page:1279—1284
21. Quantitative analysis on content of different components in Curcumae Aromaticae Radix by QAMS Page:1274—1278
22. Safety pharmacology research on Dexibuprofen injection Page:1265—1269
23. Preliminary study on constituents of extracts from stems and leaves of Aucklandia lappa and their effect of on gastric emptying and intestinal propulsion of mice Page:1259—1264
24. Considerations on nonclinical studies for immunotoxicity of monoclonal antibodies Page:1248—1253
25. Basic principles and examples on which FDA to determine whether firms' medical product communications are consistent with FDA-required labeling Page:1241—1247
26. Examination and assessment of target organ toxicity in toxicologic pathology of preclinical safety evaluation of drugs Page:1235—1240
27. Research progress on regulation mechanism of epigenetic modifications for drug transporters Page:1229—1234
28. Progress in effects of rhein on drug transporters and metabolic enzymes Page:1223—1228
29. Vital role of oligopeptide transporters in physiology and drug transport and their clinical relevance Page:1189—1196
30. Vital role of transporters in renal drug elimination Page:1216—1222
31. Mechanism of hepatic transporters and metabolic enzymes in cholestatic liver injury Page:1210—1215
32. Role of hepatic transporters and metabolic enzymes in chemical substances-induced liver injury Page:1203—1209
33. Role of drug transporters and metabolizing enzymes in pharmacokinetics of antibiotics Page:1197—1202